Business context and reporting period
NextPlat Corp filed this Form 8-K on October 6, 2026, reporting completion of its previously announced acquisition of an independent pharmacy in the Pensacola area of northwest Florida.
Key financial information
- NextPlat acquired the pharmacy and its inventory for total cash consideration of $1,485,439.
- The pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025.
- The filing provides no acquisition-related profit, cash flow, margin, debt, or liquidity figures, and does not state how the transaction was funded beyond the cash consideration.
Material changes versus the prior period
The reported material event is the completed pharmacy acquisition. The filing does not provide comparable prior-period operating results or quantify the acquisition’s expected impact on NextPlat.
Outlook, risks, and unusual items
No guidance, outlook, management commentary, contingencies, or specific risks are described in the provided filing text. The pharmacy’s name is not stated.
Investor facts to verify
- Confirm the acquired pharmacy’s identity, closing details, and whether the $1,485,439 consideration includes all transaction-related costs.
- Review subsequent financial disclosures for the acquisition’s contribution to revenue, earnings, cash flow, and integration costs.
- Assess the pharmacy’s results after 2025 and any related purchase accounting or financing disclosures.